NxStage Stock Receives a Third Buy Rating in a Row
BTIG, Piper Jaffray, and Northland Securities have all assigned Buy ratings to NxStage, which trades as NXTM on the NASDAQ. In the past quarter, more insiders have been buying the stock.
Read the full article » | Posted 04-12-2017
Related Articles
- Apply for the ASN Home Dialysis Scholarship 2025-6 Program by May 31, 2025 Posted 05-20-2025
- Vantive is Supporting ASN’s Centers of Excellence in Home Dialysis Program Posted 05-20-2025
- NKF Spring Clinical Meeting Home Dialysis Posters Posted 04-23-2025
- Visit the MEI Booth (#100) at the Upcoming ANNA National Symposium Posted 04-23-2025